Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-048159

EVP & Chief Commercial Officer sold 7,415 shares at $1.33 ($9,872)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cheng Sohanya Roshan EVP & Chief Commercial Officer 2023-09-01 Sale −7,415 $1.33 $9,872 204,086 D: show line 1 in the form
Open-market sales · 7,415 sh · avg $1.33 · $9,872
Loading xslF345X05/doc4.xml…